Company news
TheraCryf PLC news in 2022
TheraCryf PLC's news releases, calls and decks from 2022, newest first.
Grant of Options - Director/PDMR Shareholding
December 14, 2022
Evgen Pharma 'cash runway in pretty good shape'
December 12, 2022
Notice of Half Year Results
December 2, 2022
Second Price Monitoring Extn
November 30, 2022
Study started of new SFX-01 tablet formulation
November 16, 2022
SFX-01 licensing deal for up to $160.5m
October 10, 2022
Regulatory approval for healthy volunteer study
September 29, 2022
Investor Presentation
July 14, 2022
Collaboration with University of Michigan
June 13, 2022
Full Year Results
June 8, 2022
Collaboration with Università Sapienza di Roma
May 25, 2022
Manchester Breast Centre collaboration expanded
March 7, 2022
Option over new sulforaphane analogues
January 18, 2022
Progress with UK and US regulators for 2022 trials
January 11, 2022
Calls in 2022
Decks in 2022
- Evgen Pharma — H1 2022 Earnings Presentation
Earnings · 10 slides · December 2022
- Evgen Pharma — Investor Presentation (February 2022)
Investor deck · 13 slides · February 2022